COMBINATION BIOLOGIC AND SMALL MOLECULE THERAPY FOR REFRACTORY ULCERATIVE COLITIS

被引：0
|
作者：
Hickman, Kaitlyn
Jordan, Ronald
Sonnier, William
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [41] Editorial: Is vedolizumab the preferred biologic therapy for biologic-naive patients with ulcerative colitis?
    Yamamoto, Takayuki
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (05) : 546 - 547
  • [42] Biologic and Small Molecule Therapy in Atopic Dermatitis
    Shergill, Mahek
    Bajwa, Barinder
    Yilmaz, Orhan
    Tailor, Karishma
    Bouadi, Naila
    Mukovozov, Ilya
    BIOMEDICINES, 2024, 12 (08)
  • [43] Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease
    Ahmed, Waseem
    CROHNS & COLITIS 360, 2022, 4 (01)
  • [44] Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn's disease and ulcerative colitis
    Hashash, Jana G.
    Abou Fadel, Carla G.
    Rimmani, Hussein H.
    Sharara, Ala, I
    ANNALS OF GASTROENTEROLOGY, 2021, 34 (05): : 612 - 624
  • [45] Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
    Tanida, Satoshi
    Ozeki, Keiji
    Kanno, Takuya
    Katano, Takahito
    Sugimura, Naomi
    Nishie, Hirotada
    Iwasaki, Hiroyasu
    Tanaka, Mamoru
    Shimura, Takaya
    Kubota, Eiji
    Kataoka, Hiromi
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (10-11): : 510 - 514
  • [46] Antibiotic combination therapy in patients with chronic ulcerative colitis
    Ohkusa, T
    Miwa, H
    Kobayashi, O
    Terai, T
    Nomura, T
    Hojo, M
    Ohkura, R
    Takei, Y
    Ogihara, T
    Hirai, S
    Okayasu, I
    Sato, N
    GASTROENTEROLOGY, 2003, 124 (04) : A68 - A68
  • [47] Vancomycin and Ustekinumab Combination Therapy in Acute Ulcerative Colitis
    Nguyen, Khue M.
    Wright, Emily K.
    ACG CASE REPORTS JOURNAL, 2024, 11 (03)
  • [48] Ulcerative Colitis Therapy: Vedolizumab as a First-line Biologic Agent?
    Metzger, Leandra
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (03): : 274 - 276
  • [49] MICROBIOME AND EPIGENETIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPY IN PATIENTS WITH ULCERATIVE COLITIS
    Shah, Rajesh
    Shen, Lanlan
    GASTROENTEROLOGY, 2020, 158 (03) : S68 - S68
  • [50] Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy
    Nakase, Hiroshi
    Mikami, Sakae
    Matsuura, Minoru
    Ueno, Satoru
    Uza, Norimitsu
    Inoue, Satoko
    Kitamura, Hiroshi
    Kasahara, Katsuhiro
    Yoshino, Takuya
    Takeda, Yasuhiro
    Chiba, Tsutomu
    INTERNAL MEDICINE, 2007, 46 (11) : 717 - 720
12345